|
Table 1. Safety evaluation of 61 patients including 19 patients with hepatitis.
| Marker |
Entry level |
Month 2 |
P value |
P value |
| BUN |
13.83 |
12.75 |
0.42 |
0.25 |
| Creatinine |
0.98 |
0.97 |
0.32 |
0.75 |
| Total protein |
7.58 |
7.62 |
0.67 |
0.74 |
| Albumin |
4.34 |
4.30 |
0.31 |
0.68 |
| Globulin |
3.22 |
4.13 |
0.18 |
0.09 |
| Hemoglobin |
12.77 |
12.07 |
0.72 |
0.15 |
| Hematocrit |
35.90 |
36.83 |
0.82 |
0.46 |
| Total bilirubin |
0.89 |
0.65 |
5.24E-007 |
5.66E-006 |
| High bilirubin |
1.11 |
0.70 |
0.0005 |
0.0005 |
| Normal bilirubin |
0.79 |
0.62 |
8.15E-005 |
0.000007 |
| Direct bilirubin |
0.18 |
0.09 |
2.37E-007 |
0.001 |
| High AST |
47.8 |
25.6 |
0.00018 |
6.44E-006 |
| Normal AST |
25.6 |
19.9 |
3.34E-006 |
0.06 |
| High ALT |
50.1 |
25.2 |
0.0002 |
4.9E-005 |
| Normal ALT |
26.8 |
25.3 |
0.34 |
0.34 |
| Alkaline phosphatase |
95.02 |
63.33 |
0.0001 |
0.0005 |
| Platelets |
217,538.5 |
205,708.3 |
0.71 |
0.59 |
| WBC |
5,592.5 |
5,127.5 |
0.45 |
0.23 |
| Neutrophils (%) |
51.86 |
52.33 |
0.97 |
0.86 |
| Eosinophils (%) |
5.71 |
6.08 |
0.63 |
0.88 |
| Monocytes (%) |
4.49 |
5.83 |
0.003 |
0.03 |
| Basophiles (%) |
1.43 |
0.92 |
0.85 |
0.05 |
|
|